Korean Multicenter Registry Study of EPIC Stents for the Treatment of Iliac Artery Disease: K-EPIC Registry

Dae-Young KIM; Young-Guk KO; Seung-Jun LEE; Chul-Min AHN; Seung-Woon RHA; Cheol-Ung CHOI; Jong-Kwan PARK; Chang-Hwan YOON; Seung-Hyuk CHOI; Pil-Ki MIN; Jang-Whan BAE; Jung-Kyu HAN; Sang-Ho PARK; Donghoon CHOI.
Korean Circulation Journal ; : 441-451, 2021.
Artículo en Inglés | WPRIM | ID: wpr-893956

Documentos relacionados

  1. Korean Multicenter Registry Study of EPIC Stents for the Treatment of Iliac Artery Disease: K-EPIC Registry
  2. Korean Multicenter Registry Study of EPIC Stents for the Treatment of Iliac Artery Disease: K-EPIC Registry.
  3. One-year results of a balloon expandable endoprosthesis as a bridging stent for branched endovascular aortic repair.
  4. [The mid-term and long-term results of endovascular treatment of C/D aorto-iliac artery occlusive disease].
  5. Vein Bypass Versus Nitinol Stent in Long Femoropopliteal Lesions: 4-Year Results of a Randomized Controlled Trial.
  6. Effectiveness of the Pulsar-18 self-expanding stent with optional drug-coated balloon angioplasty in the treatment of femoropopliteal lesions - the BIOFLEX PEACE All-Comers Registry.
  7. Five-Year Outcomes of the Bioresorbable Peripheral Remedy Stent in the Treatment of Iliac Artery Disease.
  8. Treatment of Long Femoropopliteal Lesions With Self-Expanding Interwoven Nitinol Stent: 24 Month Outcomes of the STELLA-SUPERA Trial.
  9. Clinical outcome of endovascular therapy using a VIABAHN VBX-covered stent for complex aortoiliac artery disease: the AVOCADO II study.
  10. Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions.